Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation
Tomomi Matsuura(Keio University), Masataka Sata(Tokushima University), Tomoya Hara(Shikoku Medical Center for Children and Adults), Kenya Kusunose(University of the Ryukyus), Takayuki Ise(Tokushima University Hospital), Daiju Fukuda(Osaka City University), Takeshi Soeki(Tokushima University), Koji Yamaguchi(University of Occupational and Environmental Health Japan), Shusuke Yagi(Shikoku Central Hospital of the Mutual Aid Association of Public School Teachers), Hirotsugu Yamada(Tokushima University Hospital), Etsuko Uematsu(Tokushima University), Tetsuzo Wakatsuki(Tokushima University), Takeshi Tobiume(Tokushima University)
Cited by 16
Related Papers
Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
|Cell stem cell|2012|1.1k
Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease
|Circulation|2009|304
Accuracy of Cuff-Measured Blood Pressure
|Journal of the American College of Cardiology|2017|271
Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells
|Cell Metabolism|2016|252
Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway
|Nature Communications|2014|250